Accelrys, Inc.
bioinformatics, cheminformatics, matinformatics
The Genetics Computer Group (GCG), Oxford Molecular, MSI, and Synopsys joined together on 1 June 2001 to form the company Accelrys, which is a wholly-owned software subsidiary of Pharmacopeia Inc. On 11 May 2004, Pharmacopeia split into two companies according to its two subsidiaries. The software company will remain as Accelrys Inc.
Mark J. Emkjer (President, CEO)
Rick Russo (Senior VP & CFO)
Frank Brown (CSO)
Kenneth L. Coleman (Chairman)
Gary E. Costley
Mark J. Emkjer
Ricardo B. Levy
Christopher J. Steffen
10188 Telesis Court
Suite 100
San Diego, CA 92121
USA
Phone: +1-858-799-5000
Fax: +1-858-799-5100
Datamining software, most notably the GCG Wisconsin Package
Related patents
- No English title available
- Modeling interactions with atomic parameters including anisotropic dipole polarizability
- Apparatus and method for monitoring the validity of a molecular model
- Structure factor determinations
- Determining structure factor from X-ray crystallography data
- A method for optimising decision trees
- Method and apparatus for estimating solvation energies of membrane bound molecules
- Analysis of powder diffraction crystallography data
- Method and system for computationally estimating transition geometry between reactant and product structures
- Method and system for atom matching for reactant and product atomic and molecular systems
- Pharamcophore model generation and use
- Method of storing fast throughput experimentation information in database
Related news
- Accelrys and Agilent Technologies Extend Their Relationship with OEM Agreement
- Accelrys Announces Collaborative Agreement to Develop a Solution for the Registration of Biological Entities
- Accelrys to Offer Free Version of its Scientific Operating Platform to Academic Researchers
- Accelrys Announces the Appointment of Jeffrey Rodek, Former Executive Chairman of the Board of Directors of Hyperion Solutions Corporation, to its Board of Directors
- Accelrys Nanotechnology Consortium Delivers New Multi-scale Computer Aided Nanodesign Software Tools and Adds New Members
- Accelrys Releases Enhanced Suite of Accord Cheminformatics Solutions
- Accelrys and the Cambridge Crystallographic Data Centre Integrate the Cambridge Structural Database System with Materials Studio 4.1
- Accelrys Releases Enhanced Suite of Life Science Modeling and Simulation Tools with Discovery Studio(R) 1.6
- Accelrys Licenses SciTegic's Pipeline Pilot to Jazz Pharmaceuticals for Sales Reporting & Contact Management
- Accelrys Announces Resignation of Chief Financial Officer
- Accelrys Announces Fiscal 2006 Financial Results; Net Loss Reduced by Over 50%; Positive Operating Cash Flow of $5.8 Million; Company Completes Restatement of Historical Financial Statements
- Accelrys Announces Comprehensive, Multi-Year Agreements with Several Industry-Leading Pharmaceutical Companies
- Accelrys Receives NASDAQ Notification Regarding Late Filing of Third Quarter 2005 10-Q